40
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes

, , , , , , , , , , , , , , & show all
Pages 28-35 | Received 17 Aug 2011, Accepted 28 Feb 2012, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Masaru Kato, Yuko Kaneko, Yoshiya Tanaka, Masayuki Inoo, Hitomi Kobayashi-Haraoka, Koichi Amano, Masayuki Miyata, Yohko Murakawa, Hidekata Yasuoka, Shintaro Hirata, Hayato Nagasawa, Eiichi Tanaka, Nobuyuki Miyasaka, Hisashi Yamanaka, Kazuhiko Yamamoto, Isao Yokota, Tatsuya Atsumi & Tsutomu Takeuchi. (2020) Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study. Modern Rheumatology 30:3, pages 442-449.
Read now

Articles from other publishers (12)

A. S. Avdeeva. (2022) Inflammatory markers in rheumatic diseases. Rheumatology Science and Practice 60:6, pages 561-569.
Crossref
Marie-Astrid Boutet, Alessandra Nerviani, Gloria Lliso-Ribera, Roberto Leone, Marina Sironi, Rebecca Hands, Felice Rivellese, Annalisa Del Prete, Katriona Goldmann, Myles J. Lewis, Alberto Mantovani, Barbara Bottazzi & Costantino Pitzalis. (2021) Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response. Frontiers in Immunology 12.
Crossref
Selene Pérez-García, Valentina Calamia, Tamara Hermida-Gómez, Irene Gutiérrez-Cañas, Mar Carrión, Raúl Villanueva-Romero, David Castro, Carmen Martínez, Yasmina Juarranz, Francisco J. Blanco & Rosa P. Gomariz. (2021) Proteomic Analysis of Synovial Fibroblasts and Articular Chondrocytes Co-Cultures Reveals Valuable VIP-Modulated Inflammatory and Degradative Proteins in Osteoarthritis. International Journal of Molecular Sciences 22:12, pages 6441.
Crossref
Antonietta Stellavato, Odile Francesca Restaino, Valentina Vassallo, Elisabetta Cassese, Rosario Finamore, Carlo Ruosi & Chiara Schiraldi. (2021) Chondroitin Sulfate in USA Dietary Supplements in Comparison to Pharma Grade Products: Analytical Fingerprint and Potential Anti-Inflammatory Effect on Human Osteoartritic Chondrocytes and Synoviocytes. Pharmaceutics 13:5, pages 737.
Crossref
Iva Sorić Hosman, Ivanka Kos & Lovro Lamot. (2021) Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker. Frontiers in Immunology 11.
Crossref
Qian Wu, Fan Cao, Jinhui Tao, Xiaomei Li, Song Guo Zheng & Hai-Feng Pan. (2020) Pentraxin 3: A promising therapeutic target for autoimmune diseases. Autoimmunity Reviews 19:12, pages 102584.
Crossref
Raffaella Parente, Cristina Sobacchi, Barbara Bottazzi, Alberto Mantovani, Danka Grčevic & Antonio Inforzato. (2019) The Long Pentraxin PTX3 in Bone Homeostasis and Pathology. Frontiers in Immunology 10.
Crossref
Mohammadreza Jafari-Nakhjavani, Amir Ghorbanihaghjo, Elyar Pourghassem, Sima Abediazar, Tala Pourlak & Aida Malekmahdavi. (2019) Serum pentraxin 3 levels in rheumatoid arthritis patients and its association with disease activity. The Egyptian Rheumatologist 41:4, pages 251-254.
Crossref
Sinem Sag, Ayhan Kamanlı, Mustafa Altındis, Mustafa Serdar Sag, Halil Harman, İbrahim Tekeoglu & Kemal Nas. (2017) The relationship of pentraxin-3 levels with IL-17, fetuin-A, insulin in patients with Behçet's disease. Dermatologica Sinica 35:4, pages 195-200.
Crossref
Yong Gil Hwang, Goundappa K. Balasubramani, Ilinca D. Metes, Marc C. Levesque, S. Louis BridgesJr.Jr. & Larry W. Moreland. (2016) Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker. Arthritis Research & Therapy 18:1.
Crossref
İbrahim Tekeoğlu, Halil Harman, Sinem Sağ, Mustafa Altındiş, Ayhan Kamanlı & Kemal Nas. (2016) Levels of serum pentraxin 3, IL-6, fetuin A and insulin in patients with rheumatoid arthritis. Cytokine 83, pages 171-175.
Crossref
Kosaku MURAKAMI. (2016) Potential of specialized pro-resolving lipid mediators against rheumatic diseases. Japanese Journal of Clinical Immunology 39:3, pages 155-163.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.